Literature DB >> 29572546

The role of CD6 in autoimmune diseases.

David A Fox1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29572546      PMCID： PMC6207704          DOI： 10.1038/s41423-018-0015-1

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  23 in total

1.  Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.

Authors:  Anna Ibáñez; Maria-Rosa Sarrias; Montserrat Farnós; Idoia Gimferrer; Carles Serra-Pagès; Jordi Vives; Francisco Lozano
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

2.  DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.

Authors:  Patrick Coit; Lindsey B De Lott; Bin Nan; Victor M Elner; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2015-06-02       Impact factor: 19.103

3.  CD6: expression during development, apoptosis and selection of human and mouse thymocytes.

Authors:  Nora G Singer; David A Fox; Tariq M Haqqi; Laura Beretta; Judith S Endres; Susan Prohaska; Jane R Parnes; Jonathan Bromberg; R Michael Sramkoski
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

4.  Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Authors:  Marta Consuegra-Fernández; Marc Julià; Mario Martínez-Florensa; Fernando Aranda; Cristina Català; Noelia Armiger-Borràs; María-Teresa Arias; Francisca Santiago; Antonio Guilabert; Anna Esteve; Carlos Muñoz; Carlos Ferrándiz; José-Manuel Carrascosa; Edurne Pedrosa; Jorge Romaní; Mercè Alsina; José-Manuel Mascaró-Galy; Francisco Lozano
Journal:  Cell Mol Immunol       Date:  2017-12-11       Impact factor: 11.530

5.  CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.

Authors:  N G Singer; R Mitra; F Lialios; B C Richardson; R M Marks; J M Pesando; D A Fox; B J Nickoloff
Journal:  Immunol Lett       Date:  1997-06       Impact factor: 3.685

6.  Monoclonal anti-T12 antibody as therapy for renal allograft rejection.

Authors:  C B Carpenter; E L Milford; E L Reinherz; S F Schlossman; N L Tilney; T B Strom; R L Kirkman; G J Busch; J L Araujo
Journal:  Trans Assoc Am Physicians       Date:  1983

7.  Evidence for protein tyrosine kinase involvement in CD6-induced T cell proliferation.

Authors:  L M Osorio; C Ordonez; C A Garcia; M Jondal; S C Chow
Journal:  Cell Immunol       Date:  1995-11       Impact factor: 4.868

8.  Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12.

Authors:  D A Hafler; R J Fallis; D M Dawson; S F Schlossman; E L Reinherz; H L Weiner
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

9.  Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Authors:  D S Krupashankar; Sunil Dogra; Mahendra Kura; Abir Saraswat; Leelavathy Budamakuntla; T K Sumathy; Radha Shah; M G Gopal; T Narayana Rao; C R Srinivas; Ramesh Bhat; Narendra Shetty; G Manmohan; Kotla Sai Krishna; Dalavoi Padmaja; Dasiga Venkata Subrahmanya Pratap; Vijay Garg; Sandesh Gupta; Neeraj Pandey; Uday Khopkar; Enrique Montero; M S Ramakrishnan; Pradip Nair; Prasanna C Ganapathi
Journal:  J Am Acad Dermatol       Date:  2014-04-02       Impact factor: 11.527

10.  Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.

Authors:  M A Bowen; D D Patel; X Li; B Modrell; A R Malacko; W C Wang; H Marquardt; M Neubauer; J M Pesando; U Francke
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.